118 related articles for article (PubMed ID: 8099541)
1. Desensitization to sulphasalazine in patients with arthritis.
Koski JM
Clin Exp Rheumatol; 1993; 11(2):169-70. PubMed ID: 8099541
[TBL] [Abstract][Full Text] [Related]
2. Sulphasalazine desensitisation in patients with arthritis.
McCarthy C; Coughlan R
Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919
[TBL] [Abstract][Full Text] [Related]
3. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
Bax DE; Amos RS
Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
[TBL] [Abstract][Full Text] [Related]
4. Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
Kümmerle-Deschner J; Dannecker G
Acta Paediatr; 1995 Aug; 84(8):952-4. PubMed ID: 7488828
[TBL] [Abstract][Full Text] [Related]
5. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
Dougados M; Boumier P; Amor B
Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744
[TBL] [Abstract][Full Text] [Related]
6. Desensitization for sulfasalazine-induced skin rash in a patient with ulcerative colitis.
Akahoshi K; Chijiiwa Y; Kabemura T; Okabe H; Akamine Y; Nawata H
J Gastroenterol; 1994 Dec; 29(6):772-5. PubMed ID: 7874275
[TBL] [Abstract][Full Text] [Related]
7. Sulphasalazine in ankylosing spondylitis.
Feltelius N; Hällgren R
Ann Rheum Dis; 1986 May; 45(5):396-9. PubMed ID: 2872857
[TBL] [Abstract][Full Text] [Related]
8. [Sulfasalazine therapy in spondylarthritis ankylopoietica].
Winkler V
Orv Hetil; 1989 Jan; 130(2):77-81. PubMed ID: 2563308
[TBL] [Abstract][Full Text] [Related]
9. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis.
Mielants H; Veys EM; Joos R
Clin Rheumatol; 1986 Jan; 5(1):80-3. PubMed ID: 2869851
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of sulphasalazine in ankylosing spondylitis--an interventional study.
Fraser SM; Sturrock RD
Br J Rheumatol; 1990 Feb; 29(1):37-9. PubMed ID: 1968353
[TBL] [Abstract][Full Text] [Related]
11. Desensitization for sulfasalazine skin rash.
Purdy BH; Philips DM; Summers RW
Ann Intern Med; 1984 Apr; 100(4):512-4. PubMed ID: 6142671
[TBL] [Abstract][Full Text] [Related]
12. Sulphasalazine desensitisation.
Holdsworth CD
Br Med J (Clin Res Ed); 1981 Jan; 282(6258):110. PubMed ID: 6109553
[No Abstract] [Full Text] [Related]
13. A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect.
Corkill MM; Jobanputra P; Gibson T; Macfarlane DG
Br J Rheumatol; 1990 Feb; 29(1):41-5. PubMed ID: 1968354
[TBL] [Abstract][Full Text] [Related]
14. Facial palsy and partial accommodative insufficiency associated with sulphasalazine treatment in a patient with ankylosing spondylitis.
Magnus JH; Elverland HH; Olsen EG; Husby G
Scand J Rheumatol; 1993; 22(4):199-201. PubMed ID: 8102809
[TBL] [Abstract][Full Text] [Related]
15. [Sulfasalazine in the treatment of ankylosing spondylitis].
Krajnc I
Lijec Vjesn; 1990; 112(5-6):171-4. PubMed ID: 1978212
[TBL] [Abstract][Full Text] [Related]
16. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
Tolia V
Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis.
Hendrix S; Koenig A; Li W; Singh A
J Int Med Res; 2013 Oct; 41(5):1606-11. PubMed ID: 23975857
[TBL] [Abstract][Full Text] [Related]
18. Sulphasalazine and ankylosing spondylitis: an open pilot study.
Coelho Andrade LE; Atra E; Bosi Ferraz M
Clin Exp Rheumatol; 1989; 7(6):661-2. PubMed ID: 2575477
[No Abstract] [Full Text] [Related]
19. Should tests for proteinuria be included in the monitoring schedule of sulphasalazine?
Helliwell PS
Br J Rheumatol; 1995 Aug; 34(8):790-1. PubMed ID: 7551669
[TBL] [Abstract][Full Text] [Related]
20. Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides.
Feltelius N; Gudmundsson S; Wennersten L; Sjöberg O; Hällgren R; Klareskog L
Ann Rheum Dis; 1991 Jun; 50(6):369-71. PubMed ID: 1676256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
